Smoking Cessation: Which Options are Best? Carlat Reports

Smoking Cessation: Which Options are Best?

The Carlat Psychiatry Report, Volume 6, Number 3, March 2008
https://www.thecarlatreport.com/newsletter-issue/tcprv6n3/

From The Carlat Psychiatry Report, March 2008, Update on Substance Abuse

Issue Links: Learning Objectives | Editorial Information

Daniel Carlat, MD

The field of smoking cessation has been abuzz since the FDA approved Chantix (varenicline) in 2006. Pfizer’s studies showed better efficacy for Chantix than bupropion (Wellbutrin/Zyban), and the mechanism of action is fascinating. But several controversial issues have arisen to muddy the waters.

You can't view details of this content, please login or buy subscription here

Daniel Carlat, MD

Editor-in-Chief, Publisher, The Carlat Report.

Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.